An Auburn Doubledays player has been suspended for the use of performance-enchancing drugs.
Jonathan Pryor, a 2017 19th-round pick of the Washington Nationals, has been suspended 76 games for use of the substance dehydrochlormethyltestosterone.
The Office of the Commissioner of Baseball announced the suspension on Wednesday.
Pryor, a second-year player for the Doubledays, had been a productive player off the bench this season. In 15 games, Pryor, an outfielder, was hitting .313 with 10 hits (one double) in 32 at-bats. He scored five runs and walked three times.
According to a statement from Pryor's official Twitter account, his ban stems from a positive urine test that was taken on April 25. He was then notified about the positive test on June 6.
"I am a total advocate of MLB and MiLB's anti-drug policies, knowing I may not have had the opportunity to play professional baseball unless the sport was free of performance enchancing drugs," Pryor said in his statement.
He continued, "Anyone who knows me is aware how much I love baseball and that I would never do anything to tarnish the integrity of the game, nor put my career, reputation, or health in jeopardy.
"What allows me to rest at night is knowing I'm clean and did all I could through the appeal. I'm grateful for the support of the Nationals organization during this difficult time and regret any distraction this causes."
As of Thursday afternoon, the Doubledays and the Nationals had not commented on the suspension.
Orioles pitcher Ruben Garcia and Pirates pitcher Eddison Polonia also received bans after positive tests for PEDs.
Dehydrochlormethyltestosterone, also known as "Oral Turinabol," is an anabolic steroid that is generally ingested as a pill. According to the New York Times, the drug was developed in the 1960s by an East German drug company called Jenapharm. It was popularized by East Germany's Olympic athletes during the 1970s and 1980s.
The drug itself is meant to help muscles "retain protein to build or repair them."